Socioeconomic status may serve as a determinant of whether patients seek or have access to treatment for weight management, according to researchers presenting at AACE.
Study of levoketoconazole for Cushing’s syndrome shows significant improvements in acne, hirsutism in women, and peripheral edema.
Healthcare providers are increasingly looking for signs of opioid-induced adrenal insufficiency (OIAI) in their patients, according to a presentation made at the AACE annual meeting held in Los Angeles last week.
The hormone oxytocin shows promise as a possible new treatment for obesity, according to research presented on Monday at ENDO 2019.
Could corticosteroid use put your patients at a greater risk of metabolic syndrome?
Men’s health studies presented at ENDO 2017 included a possible prostate cancer treatment and the potential of hormone therapy to prevent frailty.
Three studies from ENDO 2017 focused on improving patient care through brain stimulation, an artificial pancreas system, and videoconferencing.
Researchers sought to discover the specific physiological pathways of fibroblast growth factor 21.
Research presented at ENDO 2017 explored options to reduce complications in patients with diabetes and microalbuminuria and patients with cystic fibrosis.
Studies presented at ENDO 2017 examined the impact of sleep disorders on gestational diabetes, bone formation, and adolescents with and without diabetes.